Both in Pharmaceuticals
Prothena vs Relmada Therapeutics
Over the past year PRTA returned −18.2% and RLMD returned +50.5%; their daily moves had a correlation of 0.19.
PRTA −18.2% RLMD +50.5%Growth of $1, one year, split-adjusted
| Metric | PRTA | RLMD |
|---|---|---|
| Price | $8.39 | $4.17 |
| Market cap | $430.7M | $444.8M |
| Today | +2.19% | −2.34% |
| 1 month | +4.6% | +27.1% |
| 6 months | −25.0% | −46.9% |
| Year to date | −12.1% | −13.7% |
| 1 year | −20.4% | +89.5% |
| Revenue growth (YoY) | −77.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −1839.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.9× | — |
| Net cash | $288.2M | $217.7M |
| Dividend yield | — | — |
| Volatility (60d) | 45.9% | 60.0% |
| Short % of float | 18.9% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).